Teleflex Inc（TFX）資訊與事件TFXTeleflex Inc

Teleflex Receives BLA Approval for EZPLAZ Freeze Dried Plasma

Teleflex announced it has received Biologics License Application (BLA) approval for EZPLAZ Freeze Dried Plasma (FDP) from the U.S. Food and Drug Administration (FDA). EZPLAZ FDP is approved for transfusion in adults with bleeding-related conditions requiring replacement of plasma coagulation factors, including uncontrolled bleeding (hemorrhage), when plasma is required and other plasma products are not available. This landmark approval is the first freeze dried plasma licensed by the FDA, and the first biologics license for a blood component for Teleflex. "EZPLAZ FDP can potentially enable the transfusion of plasma in situations where it is critically needed, including air and road ambulances, in the hospital, and on the battlefield," said Jake Newman, President and General Manager, Global Vascular and Emergency Medicine at Teleflex. "While current Emergency Use Authorization FDP products use glass bottles as containers, EZPLAZ FDP utilizes a patented flexible plastic bag technology. The BLA approval of EZPLAZ FDP is a critical milestone for our customers and for Teleflex, as we continue to expand our emergency medicine portfolio."

Teleflex Signs National Purchasing Agreement with Premier for Central Venous Access Products

Teleflex Incorporated (TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc (PINC). Effective July 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products, including short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions.